Clinical trial

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients

NCT06390904

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2022-07-13

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2022-07-13Date precision: day

Registry last updated2025-08-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Atypical Endometrial Hyperplasiaunresolved

Progesterone Resistanceunresolved

Obesityunresolved

Interventions

GnRH antagonistDRUG

Letrozole 2.5mgDRUG

Sponsors & collaborators

Xiaojun Chenlead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1 ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06390904 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.